Sugi Predict

Sugi Predict / Compounds / SCHEMBL6835829

SCHEMBL6835829

SCHEMBL6835829

Nc1ccc2c(c1N)CCCC2

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NOS3 P29474 1/20 0.47
▸ NOS1 P29475 1/20 0.47
▸ NOS2 P35228 1/20 0.47
▸ BCL2L1 Q07817 1/20 0.40
▸ BAD Q92934 1/20 0.40
▸ PARP1 P09874 1/20 0.37
▸ MEN1 O00255 3/20 0.37
▸ KMT2A Q03164 3/20 0.37
▸ KDM4E B2RXH2 3/20 0.37
▸ ALDH1A1 P00352 3/20 0.37
▸ GAA P10253 2/20 0.37
▸ MAPT P10636 2/20 0.37
▸ PKM P14618 1/20 0.37
▸ L3MBTL1 Q9Y468 1/20 0.37
▸ CES1 P23141 5/20 0.36
▸ TSHR P16473 2/20 0.36
▸ KIF11 P52732 1/20 0.35
▸ ACHE P22303 3/20 0.34
▸ LMNA P02545 1/20 0.34
▸ HPGD P15428 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8402725 0.81 NOS3 (0.47) NOS3NOS1NOS2BCL2L1BAD
SCHEMBL19830022 0.79 NOS3 (0.45) NOS3NOS1NOS2BCL2L1BAD
SCHEMBL19995842 0.77 NOS3 (0.44) NOS3NOS1NOS2BCL2L1BAD
SCHEMBL10828971 0.77 BCL2L1 (0.52) NOS3NOS1NOS2BCL2L1BAD
SCHEMBL14354818 0.77 BCL2L1 (0.47) NOS3NOS1NOS2BCL2L1BAD
SCHEMBL19995834 0.77 NOS3 (0.44) NOS3NOS1NOS2BCL2L1BAD
SCHEMBL9164030 0.77 ADRA1A (0.42) NOS3NOS1NOS2MEN1KMT2A
SCHEMBL19927065 0.77 NOS3 (0.40) NOS3NOS1NOS2BCL2L1BAD
SCHEMBL1278375 0.76 BCL2L1 (0.52) NOS3NOS1NOS2BCL2L1BAD
SCHEMBL17533482 0.76 NOS3 (0.39) NOS3NOS1NOS2BCL2L1BAD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118978525-A Light-activated labeled RNA photosensitizer based on phenothiazine, and preparation method and application thereof 大连理工大学宁波研究院 2024-11-19 — — CN claimed
CN-118978525-A Light-activated labeled RNA photosensitizer based on phenothiazine, and preparation method and application thereof 大连理工大学宁波研究院 2024-11-19 — — CN disclosed
WO-2024205665-A1 EPOXY-BASED THERMOSET POLYMERS USING MIXED AROMATIC AMINES ExxonMobil Technology and Engineering Company (US) 2024-10-03 — — WO disclosed
US-20230374214-A1 Mixed Aromatic Amine Monomers And Polymers Thereof ExxonMobil Technology and Engineering Company (US) 2023-11-23 — — US disclosed
US-20230374214-A1 Mixed Aromatic Amine Monomers And Polymers Thereof ExxonMobil Technology and Engineering Company (US) 2023-11-23 — — US disclosed
CN-114106029-B Organic molecule containing boron-nitrogen coordination bond and preparation method thereof 中国科学院长春应用化学研究所 2023-07-21 — — CN disclosed
WO-2022082148-A1 MIXED AROMATIC AMINE MONOMERS AND POLYMERS THEREOF EXXONMOBIL RESEARCH AND ENGINEERING COMPANY (US) 2022-04-21 — — WO disclosed
CN-114106029-A Organic molecule containing boron-nitrogen coordination bond and preparation method thereof 中国科学院长春应用化学研究所 2022-03-01 — — CN disclosed
WO-2020217229-A1 POLYCYCLIC COMPOUND AND AN ORGANIC ELECTROLUMINESCENCE DEVICE COMPRISING THE POLYCYCLIC COMPOUND OR THE COMPOSITION IDEMITSU KOSAN CO., LTD. (JP) 2020-10-29 — — WO disclosed
EP-2668169-B1 TETRAZOLE COMPOUNDS AND METHODS OF MAKING AND USING SAME ZAFGEN INC (US) 2017-11-15 — — EP disclosed
US-6624186-B2 Modulators of SKCa, IKCa and BKCa channels. NEUROSEARCH A/S (DK) 2003-09-23 — — US disclosed
US-20020055526-A1 Benzimidazolone-, benzoxazolone-, or benzothiazolone derivatives as ion channel modulating agents NEUROSEARCH A/S (DK) 2002-05-09 — — US disclosed
EP-1144387-A1 NEW BENZIMIDAZOLONE-, BENZOXAZOLONE-, OR BENZOTHIAZOLONE DERIVATIVES AS ION CHANNEL MODULATING AGENTS NEUROSEARCH A/S (DK) 2001-10-17 — — EP disclosed
WO-2000034248-A1 NEW BENZIMIDAZOLONE-, BENZOXAZOLONE-, OR BENZOTHIAZOLONE DERIVATIVES AS ION CHANNEL MODULATING AGENTS NEUROSEARCH A/S (DK) 2000-06-15 — — WO disclosed
EP-0283959-B1 HETEROCYCLIC COMPOUNDS AND THEIR PREPARATION AND USE NOVO NORDISK A/S (DK) 1992-01-02 — — EP disclosed
US-4889855-A ADMINISTERING GLUTAMATE ANTAGONIST TO INHIBIT HYPERACTIVITY OF EXCITATORY NEUROTRANSMITTERS A/S FERROSAN (DK) 1989-12-26 — — US disclosed
EP-0283959-A1 Heterocyclic compounds and their preparation and use NOVO NORDISK A/S (DK) 1988-09-28 — — EP disclosed
EP-0023988-A2 Use of a conductive organic charge transfer material as electron beam sensitive resist composition, and method of forming positive and negative resist images International Business Machines Corporation (US) 1981-02-18 — — EP disclosed
US-4000135-A IRON TETRAAZANNULENES AS CATALYSTS BASF AKTIENGESELLSCHAFT (DT) 1976-12-28 — — US disclosed
US-3939194-A Bis-2-azomethine pigments, process for their manufacture and their use CIBA-GEIGY CORPORATION (US) 1976-02-17 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020055526-A1 Benzimidazolone-, benzoxazolone-, or benzothiazolone derivatives as ion channel modulating agents KCNJ2, KCNJ1, KCNJ11 NOS3 2809/4885NOS1 3441/4885NOS2 3179/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.